Black Friday

All the Features.
Half the Price.

$149.00 / first year $299.50

Then $299.50/year

Last Close
0.1295
Nov 20 • 4:00 PM ET Dollar change-0.0351 Percentage change(-21.32%)
Aftermarket Close
0.1350
Aftermarket • 7:52 PM ET Dollar change+0.0055 Percentage change(4.25%)
Nov 20, 8:31 PM1-for-25 reverse split announcement sinks Co-Diagnostics 21% in Friday session
Index
-
Market Cap
1.69M
Enterprise Value
2.54M
Income
-47.48M
Sales
0.65M
Book/sh
1.29
Cash/sh
0.05
Dividend Est.
-
Dividend TTM
-
Dividend Ex-Date
-
Dividend Gr. 3/5Y
- -
Payout
-
Employees
115
IPO
Jul 12, 2017
P/E
-
Forward P/E
-
PEG
-
P/S
2.60
P/B
0.10
P/C
2.38
P/FCF
-
EV/EBITDA
-
EV/Sales
3.91
Quick Ratio
0.50
Current Ratio
0.77
Debt/Eq
0.17
LT Debt/Eq
0.09
Option/Short
No / Yes
EPS (ttm)
-18.81
EPS next Y
-0.83
EPS next Q
-0.27
EPS this Y
91.21%
EPS next Y
73.23%
EPS next 5Y
80.05%
EPS past 3/5Y
-37.47% -
Sales past 3/5Y
-76.97% -64.54%
EPS Y/Y TTM
34.53%
Sales Y/Y TTM
28.89%
EPS Q/Q
78.43%
Sales Q/Q
94.58%
Insider Own
2.61%
Insider Trans
0.00%
Inst Own
2.76%
Inst Trans
-3.13%
ROA
-165.04%
ROE
-192.78%
ROIC
-461.83%
Gross Margin
-149.31%
Oper. Margin
-4513.05%
Profit Margin
-7252.62%
SMA20
-57.98%
SMA50
-81.59%
SMA200
-93.57%
Trades
Shs Outstand
10.51M
Shs Float
10.24M
52W High
13.54 -99.04%
52W Low
0.16 -19.86%
Volatility
16.97% 17.17%
ATR (14)
0.06
RSI (14)
18.01
Beta
3.37
Rel Volume
0.57
Avg Volume
1.99M
Volume
1,143,717
Perf Week
-49.92%
Perf Month
-77.28%
Perf Quarter
-89.39%
Perf Half Y
-97.45%
Perf YTD
-97.44%
Perf Year
-98.66%
Perf 3Y
-99.70%
Perf 5Y
-99.95%
Perf 10Y
-
Prev Close
0.16
Price
0.13
Change %
-21.32%
Co-Diagnostics, Inc. engages in the development and innovation of molecular tools for detection of infectious diseases, liquid biopsy for cancer screening, and agricultural applications. Its diagnostics systems enable very rapid, low-cost, molecular testing for organisms and genetic diseases by automating historically complex procedures in both the development and administration of tests. The company was founded by Brent C. Satterfield and Dwight Howard Egan on April 18, 2013 and is headquartered in Salt Lake City, UT.
ChairmanMr. Dwight H. Egan
PresidentMr. Richard David Abbott
Executive VP of Finance & Accounting and Principal Financial & Accounting OfficerMr. Daniel Bohrer CPA
Chief Operating OfficerMr. David Nielsen
Chief Technology OfficerMr. Christopher Thurston